Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00002207 · ClinicalTrials.gov registry record · NA
A Comparison of Two Dose Levels of Didanosine Used in Combination With Stavudine in HIV-Infected Patients
A NA study, sponsored by Bristol-Myers Squibb.
- Completed
- Registry status
- NA
- Development phase
NCT00002207: Completed NA study, sponsored by Bristol-Myers Squibb.
NCT00002207 is a NA study that has completed, run by Bristol-Myers Squibb. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00002207, a NA study, has completed, sponsored by Bristol-Myers Squibb.
- COMPLETED
- Registry status
- NA
- Development phase
Study Summary
The purpose of this study is to compare the effectiveness of taking didanosine (ddI) once a day plus stavudine (d4T) twice a day with taking ddI twice a day plus d4T twice a day. This study also examines the safety of giving ddI with d4T in the short-term.
Interventions
- DRUG Stavudine
- DRUG Didanosine
Trial Details
| Field | Value |
|---|---|
| Start Date | 2004-02 |
| Est. Completion | 2004-02 |
| Phase | NA |
What the finished NCT00002207 record still lists
NCT00002207 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 2 interventions - of which Stavudine is the first listed.
NCT00002207 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00002207 about?
NCT00002207 is a clinical study titled "A Comparison of Two Dose Levels of Didanosine Used in Combination With Stavudine in HIV-Infected Patients". The purpose of this study is to compare the effectiveness of taking didanosine (ddI) once a day plus stavudine (d4T) twice a day with taking ddI twice a day plus d4T twice a day. This study also examines the safety of giving ddI with d4T in the short-term.
What is the current status of trial NCT00002207?
This trial is currently completed. It is a NA study. The study started on 2004-02. Estimated completion is 2004-02.
What interventions are being tested in trial NCT00002207?
The interventions under investigation include: Stavudine (DRUG), Didanosine (DRUG).
Who is sponsoring clinical trial NCT00002207?
This trial is sponsored by Bristol-Myers Squibb, which has 1,025 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia